| Dr Charles J Mccollum, MD | |
|
1201 7th St Se, Decatur, AL 35601-3337 | |
| (256) 341-2000 | |
| (256) 350-2609 |
| Full Name | Dr Charles J Mccollum |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1201 7th St Se, Decatur, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467419960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 00011521 (Alabama) | Primary |
| Entity Name | Anesthesia Services Of Decatur, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629034624 PECOS PAC ID: 4183618226 Enrollment ID: O20040412001701 |
News Archive
For men with type 2 diabetes, a cell type linked to allergic inflammation is closely linked to a key indicator of diabetic kidney disease (nephropathy), suggests a study in the November Clinical Journal of the American Society of Nephrology (CJASN). "Allergy is a common disease that is increasing worldwide, so our findings may have important implications for diabetic nephropathy," comments Michiaki Fukui, MD (Kyoto Prefectural University of Medicine, Japan).
The Miriam Hospital's Weight Control and Diabetes Research Center (WCDRC) recently received six research grants from the National Institutes of Health - totaling more than $12 million in funding - that will support the work of researchers focused on the prevention and treatment of obesity.
Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the close of a Series B financing totaling $20 million. The round was led by new investor Domain Associates, LLC, which was joined by existing investors including CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.
Researchers at the University of Montreal and CHU Sainte-Justine Research Centre have traced the origins of ADHD, substance abuse and conduct disorder, and found that they develop from the same neurocognitive deficits, which in turn explains why they often occur together.
Researchers at Johns Hopkins have found that in people with end-stage kidney disease (ESRD), choosing peritoneal dialysis over hemodialysis increases their risk of dying by 50 percent.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles J Mccollum, MD 1900 Flint Rd Se, Decatur, AL 35601-6031 Ph: (256) 353-0626 | Dr Charles J Mccollum, MD 1201 7th St Se, Decatur, AL 35601-3337 Ph: (256) 341-2000 |
News Archive
For men with type 2 diabetes, a cell type linked to allergic inflammation is closely linked to a key indicator of diabetic kidney disease (nephropathy), suggests a study in the November Clinical Journal of the American Society of Nephrology (CJASN). "Allergy is a common disease that is increasing worldwide, so our findings may have important implications for diabetic nephropathy," comments Michiaki Fukui, MD (Kyoto Prefectural University of Medicine, Japan).
The Miriam Hospital's Weight Control and Diabetes Research Center (WCDRC) recently received six research grants from the National Institutes of Health - totaling more than $12 million in funding - that will support the work of researchers focused on the prevention and treatment of obesity.
Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the close of a Series B financing totaling $20 million. The round was led by new investor Domain Associates, LLC, which was joined by existing investors including CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.
Researchers at the University of Montreal and CHU Sainte-Justine Research Centre have traced the origins of ADHD, substance abuse and conduct disorder, and found that they develop from the same neurocognitive deficits, which in turn explains why they often occur together.
Researchers at Johns Hopkins have found that in people with end-stage kidney disease (ESRD), choosing peritoneal dialysis over hemodialysis increases their risk of dying by 50 percent.
› Verified 6 days ago
Dr. Loyd E. Shaw, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2000 Fax: 256-350-2609 | |
Dr. George C. Faison, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-973-2000 Fax: 256-350-2609 | |
Mark A Murphy, M.D Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1852 Beltline Rd Sw, Suite G, Decatur, AL 35601 Phone: 256-340-9553 Fax: 256-340-9895 | |
Dr. David E. Tyler, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1201 7th St Se, Decatur, AL 35601 Phone: 256-341-2000 Fax: 256-350-2609 | |
Dr. Naga Raju Danthuluri, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2828 Highway 31 S, Decatur, AL 35603 Phone: 256-340-1212 | |
Mr. Charles Langdon Watkins, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1704 Summerlane Se, Decatur, AL 35601 Phone: 256-353-4073 |